MD Health
Mapping the Rare Disease Landscape for Strategic Action
The Challenge
A leading biopharmaceutical company needed a clearer, evidence-based view of how its rare disease leadership was showing up across priority markets, given how fragmented and competitive the landscape is country to country.
The Solution
MD Health is developing a rare disease benchmarking framework, combining desk research, structured analysis and a comparable rating methodology across policy, access, advocacy and diagnostics, to help identify where leadership is strong and where communications can have the greatest impact.
